The National Perinatal Hepatitis B Prevention Program, 1994-2008

Pediatrics

Volumn 129, Issue 4, 2012, Pages 609-616

  Smith, Emily A ^a   Jacques Carroll, Lisa ^b   Walker, Tanja Y ^a   Sirotkin, Barry ^c   Murphy, Trudy V ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Hepatitis B; Immunization programs; Infant; Infectious disease transmission; Newborn diseases; Pregnancy complications infectious; United States

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; BIRTH RATE; CHILD CARE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HEALTH PROGRAM; HEPATITIS B; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; JURISPRUDENCE; OUTCOME ASSESSMENT; PERINATAL HEPATITIS B PREVENTION PROGRAM; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLIC HEALTH; TREND STUDY; VACCINATION;

FEMALE; HEPATITIS B; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES; YOUNG ADULT;

EID: 84859412878     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-2866     Document Type: Article

References (45)

1. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-98 (Pubitemid 8042976)
2. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-749
3. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993;253(1337):197-201 (Pubitemid 23262603)
4. Chang M-H, You S-L, Chen C-J, et al; Taiwan Hepatoma Study Group. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101(19):1348-1355
5. Wong VCW, Ip HMH, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1(8383):921-926 (Pubitemid 14136295)
6. Centers for Disease Control and Prevention. Postexposure prophylaxis of hepatitis B. MMWR Morb Mortal Wkly Rep. 1984;33(21):285-290
7. Centers for Disease Control and Prevention. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep. 1988;37(22):341-346, 351
8. Centers for Disease Control and Prevention. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1990;39(RR-2):1-26
9. Belloni C, Tinelli C, Orsolini P, et al. Revaccination against hepatitis B virus of nonresponding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine. 1998;16(4):399-402
10. Mast EE, Margolis HS, Fiore AE, et al; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1-31
11. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR-13):1-19
12. Centers for Disease Control and Prevention. Evaluating the Effectiveness of the Programs to Prevent Hepatitis B Virus (HBV) Transmission in the United States. Atlanta, GA: Centers for Disease Control and Prevention; 1996
13. Centers for Disease Control and Prevention/National Center for Immunization and Respiratory Diseases. Perinatal hepatitis B prevention. 2008-2012 Immunization program operations manual. Available at: www.cdc.gov/vaccines/vac-gen/policies/ipom/downloads/chp-05-perinatal-hepb-508. pdf. Accessed December 6, 2010
14. Asian Liver Center at Stanford University. Hepatitis B statistics for Asians and Pacific Islanders. Available at: http://liver.stanford.edu/Education/ faq.html. Accessed January 4, 2011
15. Stevens CE, Taylor PE, Tong MJ, et al. Prevention of perinatal hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York, NY: Wiley; 1988:982-988
16. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46(4):1034-1040 (Pubitemid 350144768)
17. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202(2):192-201
18. Shuler CM, Fiore AE, Neeman R, et al. Reduction in hepatitis B virus seroprevalence among US-born children of foreign-born Asian parents - benefit of universal infant hepatitis B vaccination. Vaccine. 2009;27(43):5942-5947
19. Kohn MA, Farley TA, Scott C. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Pediatr Infect Dis J. 1996;15(6):535-540 (Pubitemid 26187800)
20. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine. 2009;27(44):6110-6115
21. Fischer G, Wang S, Ahring S, et al. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net. Pediatr Infect Dis J. 2009;28(7):593-597
22. National Immunization Survey. Estimated vaccination coverage with 3+ HepB among children 19-35 months of age by race/ethnicity, and by state and local area, 2008. US National Immunization Survey. Available at: http://www2a.cdc.gov/ nip/coverage/nis/nis-iap2.asp?fmt=r&rpt=tab24-hep-race-iap&qtr=Q1/ 2008-Q4/2008. Accessed February 14, 2011
23. Merck & Co. I. Comvax product features. Available at: www.merck.com/product/usa/pi-circulars/c/comvax/comvax-pi.pdf. Accessed October 6, 2010
24. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006;78(2):169-177 (Pubitemid 43132560)
25. Council of State and Territorial Epidemiologists. Hepatitis B prenatal screening laws or regulations. In: CSTE Position Statement 1994-13. United States; 1994 Available at: www.cste.org/ps/1994/1994-13.htm. Accessed April 12, 2011
26. Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol. 2003;102(4):753-760 (Pubitemid 37206411)
27. Willis BC, Wortley P, Wang SA, Jacques-Carroll L, Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics. 2010;125(4):704-711
28. Pierce RL, Smith S, Rowe-West B, Sterritt B. Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina. Arch Pediatr Adolesc Med. 1999;153(6):619-623 (Pubitemid 29250234)
29. Centers for Disease Control and Prevention. Prevention of perinatal hepatitis B through enhanced case management - Connecticut, 1994-95, and the United States, 1994. MMWR Morb Mortal Wkly Rep. 1996;45(27):584-587
30. Schoen E, Cohen D, Black S, Limata C; Centers for Disease Control and Prevention. Program to prevent perinatal hepatitis B virus transmission in a health-maintenance organization - Northern California, 1990-1995. MMWR Morb Mortal Wkly Rep. 1997;46(17):378-380
31. Ikeda RM, Birkhead GS, Flynn MK, Thompson SF, Morse DL. Use of multiple reporting sources for perinatal hepatitis B surveillance and follow-up. Am J Epidemiol. 1995;142(7):765-770
32. Newbern C. Assessing the completeness of perinatal hepatitis B case reporting using capture-recapture. In: National Immunization Conference. Atlanta, GA; April 19-22 2010
33. Roque D, Wang S, Jacques-Carroll L, Wasley A, Weinbaum C, Roush S; Centers for Disease Control and Prevention. Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data-United States. MMWR Morb Mortal Wkly Rep. 2011;60(13):410-413
34. Anderson TA, Wexler DL. States Report Hundreds of Medical Errors in Perinatal Hepatitis B Prevention. St Paul, MN: Immunization Action Coalition; 2009
35. Yusuf HR, Mahoney FJ, Shapiro CN, Mast EE, Polish L. Hospital-based evaluation of programs to prevent perinatal hepatitis B virus transmission. Arch Pediatr Adolesc Med. 1996;150(6):593-597 (Pubitemid 26196770)
36. Wu JS, Hwang L-Y, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis. 1999;179(6):1319-1325 (Pubitemid 29246578)
37. del Canho R., Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15(15):1624-1630 (Pubitemid 27445742)
38. Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18(7):468-473
39. Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res. 2010;40(1):31-48
40. Din ES, Wasley A, Jacques-Carroll L, Sirotkin B, Wang S. Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006. Pediatr Infect Dis J. 2011;30(7):575-579
41. Cohen C, Evans AA, London WT, Block J, Conti M, Block T. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat. 2008;15(1):12-13 (Pubitemid 350243575)
42. Rubin L, Hefer E, Dubnov Y, Warman S, Rishpon S. An evaluation of the efficiency of the national immunization programme for hepatitis B. Public Health. 2007;121(7):529-533 (Pubitemid 46908344)
43. Chan HL-Y, Jia J. Chronic hepatitis B in Asia-new insights from the past decade. J Gastroenterol Hepatol. 2011;26(suppl 1):131-137
44. Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district. Ann Trop Med Parasitol. 2009;103(6):519-527
45. Mahoney FJ, Smith N, Alter MJ, Margolis H. Progress towards the elimination of hepatitis B virus transmission in the United States. Viral Hepatitis Reviews. 1997;3(2):105-119